University of Birmingham

Researchers identify possible treatment for spinal cord injury 

20 May 2022

An existing drug could help reduce spinal cord injury damage, scientists at the University of Birmingham have discovered.   A team of scientists from the University of Birmingham found that an enzyme inhibitor developed by AstraZeneca can significantly reduce ‘secondary damage’ caused by the body’s response to spinal cord injury.   The team used animal models to […]

This week in drug discovery (25-29 April)  

29 April 2022

News round-up by DDW’s Reece Armstrong for 25-29 April     Q1 earnings, formulations to tackle blindness, liver cancer therapies and opportunities for malaria treatments are some of the themes of this week’s news round-up.  What’s behind GSK’s strong Q1 earnings?  DDW Deputy Editor Reece Armstrong looks at the key points of GSK’s first quarter earnings. UK […]

New spinout to tackle blindness with novel gel  

27 April 2022

A new spinout has launched from the University of Birmingham targeting treatments for the leading causes of preventable blindness.  Healome Therapeutics is developing a platform that delivers a ‘pro-healing’ microenvironment for causes of preventable blindness. The company’s platform will be targeted at ocular surface diseases, which are notoriously challenging conditions to treat, and have progressively […]